Source: Ecancermedicalscience. Unidade: EEL
Subjects: PROGNÓSTICO, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Rogerio Agenor de et al. Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker. Ecancermedicalscience, v. 16, n. 1431, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.3332/ecancer.2022.1431. Acesso em: 03 set. 2024.APA
Araujo, R. A. de, Monteiro, M. L. G. dos R., Bernardino Neto, M., Silva, M. J. B., LUZ, F. A. C. da, Marinho, E. da C., et al. (2022). Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker. Ecancermedicalscience, 16( 1431), 1-16. doi:10.3332/ecancer.2022.1431NLM
Araujo RA de, Monteiro MLG dos R, Bernardino Neto M, Silva MJB, LUZ FAC da, Marinho E da C, Nascimento CP, Marques L de A, Delfino PFR, Antonioli RM, Araújo BJ, Silva ACAL da. Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker [Internet]. Ecancermedicalscience. 2022 ;16( 1431): 1-16.[citado 2024 set. 03 ] Available from: https://doi.org/10.3332/ecancer.2022.1431Vancouver
Araujo RA de, Monteiro MLG dos R, Bernardino Neto M, Silva MJB, LUZ FAC da, Marinho E da C, Nascimento CP, Marques L de A, Delfino PFR, Antonioli RM, Araújo BJ, Silva ACAL da. Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker [Internet]. Ecancermedicalscience. 2022 ;16( 1431): 1-16.[citado 2024 set. 03 ] Available from: https://doi.org/10.3332/ecancer.2022.1431